Gamze Serın

5PUBLICATIONS
111CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 12, 2026
Prognostic Role of Inflammatory Indices and Real-World Outcomes in HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab Emtansine.

|Feb 11, 2026
Real-world effectiveness and safety of brigatinib in advanced ALK-positive NSCLC: a nationwide multicenter study by the Turkish Oncology Group.

Salih Tunbekici, Hamit Bal, Oguzcan Kınıkoglu

|Dec 19, 2025
The efficacy of targeted therapies in metastatic squamous cell carcinoma of the lung: a Turkish Oncology Group multicentre study.

Bilgeşah Kılıçtaş, Murat Araz, Ahmet Oruç

|Sep 19, 2025
Real-world comparison of cabozantinib and sunitinib in advanced non-clear cell renal cell carcinoma: A multicenter study by the Turkish Oncology Group.

Gökhan Şahin, Esmanur Kaplan Tüzün, Halil G Güzel

|Jul 30, 2025
Impact of Treatment Duration in First-Line Atezolizumab Plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer: A Multicenter Real-World Retrospective Study.

Mehmet Nuri Baser, Bilgin Demir, Gamze Serin Ozel

Pageof 1

Frequent Collaborators

3 joint publications

Melek Karakurt Eryılmaz

3 joint publications

Elif Şahin

3 joint publications

Kursat Dıslı

2 joint publications

Gamze Gokoz Dogu